Defective immunoglobulin class switching in Vav-deficient mice is attributable to compromised T cell help

European Journal of Immunology

Volumn 29, Issue 2, 1999, Pages 477-487

  Gulbranson Judge, Adam ^a   Tybulewicz, Victor L J ^b   Walters, Alice E ^b   Toellner, Kai Michael ^a   MacLennan, Ian C M ^a   Turner, Martin ^b,c  

^a UNIVERSITY DEPARTMENT OF MEDICINE   (United Kingdom)

^b NATIONAL INSTITUTE FOR MEDICAL RESEARCH   (United Kingdom)

^c BABRAHAM INSTITUTE   (United Kingdom)

Author keywords

Isotype switching; Knockout; Lymphocyte; T cell B cell collaboration; Transgenic

Indexed keywords

B LYMPHOCYTE ANTIGEN; CELL RECEPTOR; FICOLL; GUANINE NUCLEOTIDE EXCHANGE FACTOR; GUANOSINE TRIPHOSPHATASE; HAPTEN; HELPER FACTOR; IMMUNOGLOBULIN CLASS; IMMUNOGLOBULIN G; INTERLEUKIN 4; MESSENGER RNA; RHO FACTOR; T LYMPHOCYTE RECEPTOR;

ANIMAL CELL; ANTIBODY RESPONSE; ARTICLE; B LYMPHOCYTE; CELL MATURATION; CELL PROLIFERATION; CHIMERA; CONTROLLED STUDY; GENE REARRANGEMENT; GERMINAL CENTER; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; THYMOCYTE; TRANSGENIC MOUSE;

ANIMALS; B-LYMPHOCYTES; CELL CYCLE PROTEINS; GENE EXPRESSION REGULATION; IMMUNOGLOBULIN CLASS SWITCHING; LYMPHOCYTE ACTIVATION; LYMPHOCYTE COOPERATION; MICE; MICE, KNOCKOUT; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-VAV; T-LYMPHOCYTES;

EID: 0033065116     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1521-4141(199902)29:02<477::AID-IMMU477>3.0.CO;2-V     Document Type: Article

References (41)

1. Katzav, S., Martin-Zanca, D. and Barbacid, M., Vav, a novel human oncogene derived from a locus ubiquitously expressed in hematopoietic cells. EMBO J. 1989. 8: 2283-2290.
2. Adams, J. M., Houston, H., Allen, J., Lints, T. and Harvey, R., The hematopoietically expressed vav protooncogene shares homology with the dbl GDP-GTP exchange factor, the bcr gene and a yeast gene (CDC24) involved in cytoskeletal organization. Oncogene 1992. 7: 611-618.
3. Collins, T., Deckert, M. and Altman, A., Views on Vav. Immunot. Today 1997. 18: 221-225.
4. Crespo, P., Schuebel, K. E., Ostrom, A. A., Gutkind, J. S. and Bustelo, X. R., Phosphotyrosine-dependent activation of Rac-1 GDP/GTP exchange by the Vav protooncogene product. Nature 1997. 385: 169-172.
5. Han, J., Luby-Phillips, K., Das, B., Shu, X., Xia, Y., Mosteller, R.D., Murali-Krishna, U., Falck, J. R., White, M. A. and Broek, D., Role of Substrates and Products of Pl 3-kinase in Regulating Activation of Rac-Related Guanosine Triphosphates by Vav. Science 1998. 279: 558-560.
6. Van Aelst, L. and D'Souza-Schorey, C., Rho GTPases and signalling networks. Genes Dev. 1997. 11: 2295-2322.
7. Turner, M., Mee, P. J., Walters, A. E., Quinn, M. E., Mellor, A. L, Zamoyska, R. and Tybulewicz, V. L. J., A requirement for the Rho-Family GTP Exchange Factor Vav in Positive and Negative Selection of Thymocytes. Immunity 1997. 7: 451-460.
8. Fischer, K. D., Y., K.-Y, Nishina, H., Tedford, K., Marengere, L. E. M., Kozieradzki, I., Sasaki, T., Starr, M., Chan, G., Gardener, S., Nghiem, M. P., Bouchard, D., Barbacid, M., Bernstein, A. and Penninger, J. M., Vav is a regulator of cytoskeletal reorganisation mediated by the T-cell receptor. Curr. Biol. 1998. 8: 554-562.
9. Holsinger, L. J., Graef, I. A., Swat, W., Chi, T., Bautista, D. M., Davidson, L., Lewis, R. S., Alt, F. W. and Crabtree, G. R., Defects in actin-cap formation in Vav-deficient mice implicate an actin requirement for lymphocyte signal transduction. Curr. Biol. 1998. 8: 563-572.
10. O'Rourke, L, Tooze, R., Turner, M., Sandoval, D. M., Carter, R. H., Tybulewicz, V. L. J. and Fearon, D. T., CD19 as a membrane-Anchored Adaptor protein of B Lymphocytes: Costimulation of Lipid and protein Kinases by Recruitment of Vav. Immunity 1998. 8: 635-645.
11. Wu, J., Motto, D. G., Koretzky, G. A. and Weiss, A., Vav and SLP-76 infract and functionally cooperate in IL-2 gene activation. Immunity 1996. 4: 593-602.
12. Holsinger, L. J., Spencer, D. M., Austin, D. J., Schreiber, S. L and Crabtree, G. R., Signal transduction in T lymphocytes using a conditional allele of Sos. Proc. Natl. Acad. Sci. USA 1995. 92: 9810-9814.
13. vav activity. Mol. Cell. Biol. 1995. 15: 4337-4346.
14. Tarakhovsky, A., Turner, M., Schaal, S., Mee, P. J., Duddy, L. P., Rajewsky, K. and Tybulewicz, V. L., Defective antigen receptor-mediated proliferation of B and T cells in the absence of Vav. Nature 1995. 374: 467-470.
15. Zhang, R., Alt, F. W., Davidson, L., Orkin, S. H. and Swat, W., Defective signalling through the T- and B-cell antigen receptors in lymphoid cells lacking the Vav proto-oncogene. Nature 1995. 374: 470-473.
16. Howard, M., Farrar, J., Hilfiker, M., Johnson, B., Takatsu, K., Hamaoka, T. and Paul, W. E., Identification of a T Cell-Derived B Cell Growth Factor Distinct from interleukin 2. J. Exp. Med. 1982. 155: 914-923.
17. Gulbranson-Judge, A. and MacLennan, I., Sequential antigen-specific growth of T cells in the T zones and follicles in response to pigeon cytochrome c. Eur. J. Immunol. 1996. 26: 1830-1837.
18. Hedrick, S. M., Engel, I., McElligott, D. L., Fink, P. J., Hsu, M.-L., Hansburg, D. and Matis, L. A., Selection of Amino Acid sequences in the Beta Chain of the T cell Antigen Receptor. Science 1988. 239: 1541-1544.
19. Toellner, K.-M., Gulbranson-Judge, A., Taylor, D. R., Sze, D. M. Y. and MacLennan, I. C. M., Immunoglobulin switch transcript production in vivo related to the site and time of antigen-specific B cell activation. J. Exp. Med. 1996. 183: 2303-2312.
20. Toellner, K.-M., Luther, S. A., Sze, D. M.-Y., Choy, R. K.-W., Taylor, D. R., MacLennan, I. C. M. and Acha Orbea, H., T helper 1 (Th1) and Th2 characteristics start to develop during T cell priming and are associated with an immediate ability to induce immunoglobulin class switching. J. Exp. Med. 1998. 187: 1193-1204.
21. Engel, P., Zhou, L-J., Ord, D. C., Sato, S., Koller, B. and Tedder, T. R, Abnormal B Lymphocyte Development, Activation, and Differentiation in Mice that lack or Overexpress the CD19 Signal Transduction Molecule. Immunity 1995. 3: 39-50.
22. Rickert, R. C., Rajewsky, K. and Roes, J., Impairment of T-cell-dependent B-cell responses and B1 cell development in CD19-deficient mice. Nature 1995. 376: 352-355.
23. Tarakhovsky, A., Bar Mitzvah for B-1 cells: how will they grow up? J. Exp. Med. 1997. 185: 981-984.
24. Weng, W. K., Jarvis, L. and LeBien, T. W., Signaling through CD19 activates Vav/mitogen-activated protein kinase pathway and induces formation of a CD19/Vav/ phosphatidylinositol 3-kinase complex in human B cell precursors. J. Biol. Chem. 1994. 269: 32514-32521.
25. Krop, L, de Fougerolles, A. R., Hardy, R. R., Allison, M., Schlissel, M. S. and Fearon, D. T., Self-renewal of B-1 lymphocytes is dependent on CD19. Eur. J. Immunol. 1996. 26: 238-242.
26. Sato, S., Steeber, D. A. and Tedder, T. F., The CD19 signal transduction molecule is a response regulator of B-lymphocyte differentiation. Proc. Natl. Acad. Sci. USA 1995. 92: 11558-11562.
27. Renshaw, B. R., Fanslow III, W. C., Armitage, R. J., Campbell, K. A., Liggitt, D., Wright, B., Davison, B. L. and Malsizewski, C. R., Humoral-immune responses in CD40 ligand-deficient mice. J. Exp. Med. 1994. 180: 1889-1900.
28. Kawabe, T., Naka, T, Yoshida, K., Tanaka, T, Fujiwara, H. and Suematsu, S., The immune-responses in CD40-deficient mice-impaired immunoglobulin class switching and germinal center formation. Immunity 1994. 1:167-178.
29. Xu, J., Foy, T., Laman, J., Elliott, E., Dunn, J., Waldschmidt, T., Elsemore, J., Noelle, R. and Flavell, R., Mice deficient for the CD40 ligand [published erratum appears in Immunity 1994. 1: following 613]. Immunity 1994. 1:423-431.
30. Ronchese, R, Haussman, B., Hubele, S. and Lane, P. J. L., Mice transgenic for a soluble form of murine CTLA-4 show enhanced expansion of antigen-specific CD4(+) T cells and defective antibody production in vivo. J. Exp. Med. 1994. 179.
31. Lenschow, D. L., Herold, K. C., Rhee, L., Patel, B., Koons, A., Quin, H.-Y., Fuchs, E., Singh, B., Thompson, C. B. and Bluestone, J. A., CD28/B7 regulation of Th1 and Th2 subsets in the development of autoimmune diabetes. Immunity 1996. 5: 285-293.
32. Borriello, F., Sethna, M., Boyd, S., Schweitzer, A., Tivol, E., Jacoby, D., Strom, T., Simpson, E., Freeman, G. and Sharpe, A., B7-1 and B7-2 have overlapping, critical roles in immunoglobulin class switching and germinal center formation. Immunity 1997. 6: 303-313.
33. Ferguson, S., Han, S., Kelsoe, G. and Thompson, C., CD28 is required for germinal center formation. J. Immunol. 1996. 156: 4576-4581.
34. Kopf, M., Legros, M., Bachmann, M., Lamers, M. C., Bleuthmann, H. and Kohler, G., Disruption of the murine IL-4 gene blocks Th2 cytokine responses. Nature 1993. 362: 245-248.
35. Kuhn, R., Rajewsky, K. and Muller, W., Generation and analysis of interleukin-4 deficient mice. Science 1991. 254: 707-710.
36. Rao, A., Luo, C. and Hogan, P. C., Transcription factors of the NF-AT family: regulation and function. Annu. Rev. Immunol. 1997. 15: 707-747.
37. Ranger, A. M., Hodge, M. R., Gravallse, E. M., Oukka, M., Davidson, L., Alt, F. W., de la Brousse, F. C., Hoey, T., Grusby, M. and Glimcher, L. H., Delayed Lymphoid Repopulation with Defects in IL-4-Driven Responses Produced by Inactivation of NF-ATc. Immunity 1998. 8: 125-134.
38. Yoshida, H., Nishina, H., Takimoto, H., Marengere, L. E. M., Wakeham, A., Bouchard, D., Kong, Y.-Y., Ohteki, T., Shahinian, A., Bachmann, M., Ohashi, P. S., Penninger, J. M., Crabtree, G. R. and Mak, T. W., The transcription factor NF-ATd Regulates Lymphocyte Proliferation and Th2 Cytokine production. Immunity 1998. 8: 115-124.
39. Hodge, M. R., Ranger, A. M., de la Brousse, F. C., Hoey, T., Grusby, M. J. and Glimcher, L. H., Hyperproliferation and Dysregulation of IL-4 Expression in NF-ATp-Deficient mice. Immunity 1996. 4: 397-405.
40. Svetic, A., Finkelman, F. D., Jian, Y. C., Dieffenbach, C. W., Scott, D. E., McCarthy, K. F., Steinberg, A. D. and Gause, W. G., Cytokine Gene Expression After in vitro Primary Immunisation with Goat Antibody to Mouse IgD Antibody. J. Immunol. 1991. 147: 2391-2397.
41. Weibel, E. R., Principles and Methods for the morphometric study of the lung and other organs. Lab. Invest. 1963. 12: 131-155.